WILBUR ROSS JOINS 28 CAPITAL ADVISORY BOARD
- Editor
- 6 days ago
- 1 min read
Whats Happening:
28 Capital, a Boston-based life sciences venture firm, has announced that former Secretary of Commerce Wilbur Ross has joined the fund as a Special Advisor and investor. Ross, known for his extensive experience in finance and restructuring, will bring his expertise to 28 Capital's mission of creating biotech platforms based on discoveries by Nobel Prize Laureates and other world-class scientists.
Key Moves:
Wilbur Ross joins 28 Capital as Special Advisor and investor
28 Capital focuses on biotech platforms based on Nobel Prize Laureates' discoveries
Ross brings extensive finance and restructuring experience to the fund
By The Numbers:
Ross restructured over $400 billion of assets in his career
Ross is elected to both Private Equity and Turnaround Management Halls of Fame
Ross has served on more than 100 corporate boards
Key Quotes:
"28 Capital creates broad biotech platforms spawning multiple therapeutic products based on fundamental discoveries by Nobel Prize Laureates and other world-class scientists from top universities," said Wilbur Ross.
"I have spent time diligencing 28 Capital's platform and the science behind it, and I believe deeply in its potential to create a lasting impact on the future of medicine," Ross continued.
"I am confident in John and Audrey and really look forward to building the next generation of breakthroughs in biotech with them," Ross concluded.
Bottom Line:
The addition of Wilbur Ross to 28 Capital's advisory board brings significant financial and restructuring expertise to the life sciences venture firm. His involvement could potentially accelerate the fund's ability to create and scale biotech platforms based on cutting-edge scientific discoveries, potentially leading to breakthroughs in medicine and healthcare.
Comentarios